









市場行情
/
股票
/
nasdaq-dmaau
/

Drugs Made In America Acquisition Corp

DMAAU

10.490USD

0.000

收盤 12/19, 16:00（美東）報價延遲15分鐘

0.00總市值

--本益比TTM



Drugs Made In America Acquisition Corp

10.490

0.000

概覽公司財務分析

概覽

公司

財務

分析

關於 Drugs Made In America Acquisition Corp 公司

Drugs Made In America Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The Company intends to focus its search for businesses in the pharmaceutical industry. The Company has neither engaged in any operations nor generated any revenues.

Drugs Made In America Acquisition Corp簡介



公司代碼DMAAU

公司名稱Drugs Made In America Acquisition Corp

上市日期Jan 28, 2025

CEOStockwell (Lynn)

員工數量- -

證券類型Unit

年結日- -

公司地址1 East Broward Boulevard

城市FT LAUDERDALE

上市交易所NASDAQ OMX - NASDAQ BASIC

國家United States of America

郵編33301

電話19548703099

網址

公司代碼DMAAU

上市日期Jan 28, 2025

CEOStockwell (Lynn)

Drugs Made In America Acquisition Corp公司高管



名稱

名稱/職務

職務

持股

持股變動

Dr. G. Sridhar Prasad

Independent Director Nominee

Mr. Myron W. Shulgan

Independent Director Nominee

Ms. Lynn Stockwell

Executive Chairman of the Board, Chief Executive Officer

Dr. Catherine Do

Independent Director Nominee

Mr. Saleem Elmasri, CPA

Chief Financial Officer, Principal Financial and Accounting Officer

名稱

名稱/職務

職務

持股

持股變動

Dr. G. Sridhar Prasad

Independent Director Nominee

Mr. Myron W. Shulgan

Independent Director Nominee

Ms. Lynn Stockwell

Executive Chairman of the Board, Chief Executive Officer

Dr. Catherine Do

Independent Director Nominee

Mr. Saleem Elmasri, CPA

Chief Financial Officer, Principal Financial and Accounting Officer

收入明細

由於公司未披露，未能獲取相關數據

由於公司未披露，未能獲取相關數據

業務

地區

由於公司未披露，未能獲取相關數據

股東統計

更新時間: 11月17日週一

持股股東

股東類型

持股股東

佔比

Drugs Made In America Acquisition LLC

17.88%

Kryger Capital Limited

1.28%

Wolverine Asset Management, LLC

0.55%

RiverNorth Capital Management LLC

0.44%

Clear Street Group Inc

0.20%

其他

79.65%

持股股東

佔比

Drugs Made In America Acquisition LLC

17.88%

Kryger Capital Limited

1.28%

Wolverine Asset Management, LLC

0.55%

RiverNorth Capital Management LLC

0.44%

Clear Street Group Inc

0.20%

其他

79.65%

股東類型

持股股東

佔比

Corporation

17.88%

Investment Advisor

1.56%

Investment Advisor/Hedge Fund

0.65%

Hedge Fund

0.61%

Research Firm

0.20%

其他

79.11%

機構持股



更新時間: 12月8日週一

報告期間

機構數

持股數

持股佔比

持股變動

2025Q4

706.12K

14.40%

2025Q3

706.12K

14.40%

-280.00K

2025Q2

986.13K

14.72%

-2.41M

2025Q1

3.40M

0.80%

+3.21M

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

Drugs Made In America Acquisition LLC

4.19M

17.88%

+4.19M

Feb 18, 2025

Wolverine Asset Management, LLC

130.00K

0.55%

Jun 30, 2025

RiverNorth Capital Management LLC

420.50K

1.79%

Jun 30, 2025

Clear Street LLC

45.92K

0.2%

+40.07K

+685.09%

Jun 30, 2025

Robinson Capital Management, LLC

30.00K

0.13%

+20.00K

+200.00%

Jun 30, 2025

Tuttle Capital Management, LLC

20.00K

0.09%

-20.00K

-50.00%

Jun 30, 2025

UBS Financial Services, Inc.

18.39K

0.08%

+107.00

+0.59%

Jun 30, 2025

Citadel Advisors LLC

14.03K

0.06%

-1.73K

-10.96%

Jun 30, 2025

持股ETF



更新時間: 12月6日週六

機構名稱

佔比

CrossingBridge Pre-Merger SPAC ETF

SPAC and New Issue ETF

RiverNorth Enhanced Pre-Merger SPAC ETF

CrossingBridge Pre-Merger SPAC ETF

佔比0%

SPAC and New Issue ETF

佔比0%

RiverNorth Enhanced Pre-Merger SPAC ETF

佔比0%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

常見問題

Drugs Made In America Acquisition Corp的前五大股東是誰？



Drugs Made In America Acquisition Corp的前五大股東如下：
Drugs Made In America Acquisition LLC
持有股份：4.19M
佔總股份比例：17.88%。
Wolverine Asset Management, LLC
持有股份：130.00K
佔總股份比例：0.55%。
RiverNorth Capital Management LLC
持有股份：420.50K
佔總股份比例：1.79%。
Clear Street LLC
持有股份：45.92K
佔總股份比例：0.20%。
Robinson Capital Management, LLC
持有股份：30.00K
佔總股份比例：0.13%。